
- This event has passed.
The virtual renal cancer MDT meeting
11th February 2021 @ 6:00 pm - 7:30 pm
£6 – £20In the past decade, there have been significant advances in the management of renal cancer with better ablation technologies, robotic nephron-sparing surgery, and a plethora of chemotherapy agents. Using carefully chosen cases and an MDT (multidisciplinary team) format, this webinar will update you on the latest evidence.
This webinar will review all relevant information from an MDT perspective about real cases. The cases have been selected to highlight some of the topical and controversial issues.
Topics to be covered:
- Current indications for and limitations of ablation therapy in small renal masses.
- The pros and cons of robotic partial nephrectomy versus ablation.
- The latest evidence for surveillance of small renal masses in the elderly.
- Whether there is a role for adjuvant chemotherapy in high-risk renal cancer.
- Current indications for cytoreductive nephrectomy.
